Literature DB >> 23354230

Redefining massive transfusion when every second counts.

Stephanie A Savage1, Ben L Zarzaur, Martin A Croce, Timothy C Fabian.   

Abstract

BACKGROUND: The massive transfusion (MT) concept (>10-U packed red blood cells per 24 hours) is retrospective, arbitrary, and prone to survivor bias. Accounting for rate and timing is a more accurate conceptual framework. We redefined MT as a critical administration threshold (CAT) of 3 U/h, which is clinically pertinent and reflects hemorrhagic shock. The purpose of this study was to compare the traditional form of MT to a CAT definition in predicting mortality.
METHODS: Patients receiving transfusion in the first 24 hours were included. Precise transfusion times for each unit, in minutes, were calculated from time of injury. MT and CAT were compared to determine risk of death. Univariate and multivariate analyses were used to examine inpatient mortality.
RESULTS: A total of 169 patients(70%, >10 New Injury Severity Score [NISS]) were studied; 46% were CAT+; 22% met the MT criteria. With logistic regression, a CAT of 3 U/h (CAT+) was more predictive of death compared with 2, 4, 5, or 6 U/h. CAT was met once (CAT 1), twice (CAT 2) or more than 3 times (CAT 3) in 21%, 14%, and 11%, respectively. Increasing CAT was associated with increased mortality. CAT identified 75% of all deaths; MT only identified 33% and failed to identify 42% of CAT+ deaths. CAT (relative risk [RR] 3.58; 95% confidence interval [CI] 1.80-7.15) had a stronger association with mortality compared with MT(RR, 1.82; 95% confidence interval, 1.02-3.26).
CONCLUSION: The traditional definition of MT is inadequate to reflect illness severity. Using CATs allows prospective identification of critically ill trauma patients and eliminates survivor bias. CAT may serve as an activation trigger for transfusion protocols, allowing early identification of patients with critical transfusion requirements. Clinical trials involving transfusion strategies should consider CAT as an instrument for evaluating outcomes. LEVEL OF EVIDENCE: Diagnostic/prognostic study, level II.

Entities:  

Mesh:

Year:  2013        PMID: 23354230     DOI: 10.1097/TA.0b013e31827a3639

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  33 in total

1.  Empiric transfusion strategies during life-threatening hemorrhage.

Authors:  Geoffrey R Nunns; Ernest E Moore; Gregory R Stettler; Hunter B Moore; Arsen Ghasabyan; Mitchell Cohen; Benjamin R Huebner; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  Surgery       Date:  2018-04-27       Impact factor: 3.982

2.  Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.

Authors:  John B Holcomb; Barbara C Tilley; Sarah Baraniuk; Erin E Fox; Charles E Wade; Jeanette M Podbielski; Deborah J del Junco; Karen J Brasel; Eileen M Bulger; Rachael A Callcut; Mitchell Jay Cohen; Bryan A Cotton; Timothy C Fabian; Kenji Inaba; Jeffrey D Kerby; Peter Muskat; Terence O'Keeffe; Sandro Rizoli; Bryce R H Robinson; Thomas M Scalea; Martin A Schreiber; Deborah M Stein; Jordan A Weinberg; Jeannie L Callum; John R Hess; Nena Matijevic; Christopher N Miller; Jean-Francois Pittet; David B Hoyt; Gail D Pearson; Brian Leroux; Gerald van Belle
Journal:  JAMA       Date:  2015-02-03       Impact factor: 56.272

Review 3.  [Hypovolemic and hemorrhagic shock].

Authors:  H Lier; M Bernhard; B Hossfeld
Journal:  Anaesthesist       Date:  2018-03       Impact factor: 1.041

4.  The Massive Transfusion Score as a decision aid for resuscitation: Learning when to turn the massive transfusion protocol on and off.

Authors:  Rachael A Callcut; Michael W Cripps; Mary F Nelson; Amanda S Conroy; Bryce B R Robinson; Mitchell J Cohen
Journal:  J Trauma Acute Care Surg       Date:  2016-03       Impact factor: 3.313

5.  Association Between Ratio of Fresh Frozen Plasma to Red Blood Cells During Massive Transfusion and Survival Among Patients Without Traumatic Injury.

Authors:  Tomaz Mesar; Andreas Larentzakis; Walter Dzik; Yuchiao Chang; George Velmahos; Daniel Dante Yeh
Journal:  JAMA Surg       Date:  2017-06-01       Impact factor: 14.766

Review 6.  Optimal Fluid Therapy for Traumatic Hemorrhagic Shock.

Authors:  Ronald Chang; John B Holcomb
Journal:  Crit Care Clin       Date:  2017-01       Impact factor: 3.598

7.  Clinical gestalt and the prediction of massive transfusion after trauma.

Authors:  Matthew J Pommerening; Michael D Goodman; John B Holcomb; Charles E Wade; Erin E Fox; Deborah J Del Junco; Karen J Brasel; Eileen M Bulger; Mitch J Cohen; Louis H Alarcon; Martin A Schreiber; John G Myers; Herb A Phelan; Peter Muskat; Mohammad Rahbar; Bryan A Cotton
Journal:  Injury       Date:  2015-02-04       Impact factor: 2.586

8.  Collider bias in trauma comparative effectiveness research: the stratification blues for systematic reviews.

Authors:  Deborah J Del Junco; Eileen M Bulger; Erin E Fox; John B Holcomb; Karen J Brasel; David B Hoyt; James J Grady; Sarah Duran; Patricia Klotz; Michael A Dubick; Charles E Wade
Journal:  Injury       Date:  2015-01-31       Impact factor: 2.586

9.  A joint latent class analysis for adjusting survival bias with application to a trauma transfusion study.

Authors:  Jing Ning; Mohammad H Rahbar; Sangbum Choi; Chuan Hong; Jin Piao; Deborah J del Junco; Erin E Fox; Elaheh Rahbar; John B Holcomb
Journal:  Stat Med       Date:  2015-08-09       Impact factor: 2.373

10.  Seven deadly sins in trauma outcomes research: an epidemiologic post mortem for major causes of bias.

Authors:  Deborah J del Junco; Erin E Fox; Elizabeth A Camp; Mohammad H Rahbar; John B Holcomb
Journal:  J Trauma Acute Care Surg       Date:  2013-07       Impact factor: 3.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.